Priority Date: 06.06.08 (EP 20080290520)

MACROCYCLIC UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIA

  • Application ID: EP09757185
  • Status: No opposition filed within time limit

Applicants

Technology company logo small
Technology Company
Technology company logo small
Technology Company

Attorney

no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Sanofi-Aventis Deutschland GmbH is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 221 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 06.06.2008 - Priority Date (EP 20080290520)
  • 10.12.2009 - Publication A1 (WO2009146802)
  • 30.03.2011 - Publication A1 (EP2300462)
  • 21.05.2014 - Publication B1 (EP2300462)